论文部分内容阅读
目的:探讨过敏性鼻炎和哮喘的联合诊治方法,总结临床治疗经验。方法:选择本院于2016年1月-2017年1月间所收治的90例过敏性鼻炎并哮喘患者为研究对象,随机均分成观察组(45例)和对照组(45例)。对照组中患者均给予舒利迭沙美特罗替卡松粉吸入剂进行治疗,观察组在对照组的给予上,给予患者雷诺考特布地奈德鼻喷雾进行治疗,对比分析两组患者在接受治疗一段时期后的治疗疗效。结果:在接受治疗一段时间后,观察组患者的肺功能评分、ACT评分以及过敏性鼻炎评分均显著优于对照组,二组间各项指标的差异具有显著性,具有统计学意义(P<0.05)。结论:通过对过敏性鼻炎并哮喘患者采用联合诊治手段,不仅有助于缓解患者的各种疾病病症,提升患者治疗效果,也有助于改善患者生活质量,值得在临床上进行推广与应用。
Objective: To explore the method of joint diagnosis and treatment of allergic rhinitis and asthma and to summarize the experience of clinical treatment. Methods: 90 patients with allergic rhinitis and asthma admitted in our hospital from January 2016 to January 2017 were randomly divided into observation group (45 cases) and control group (45 cases). Patients in the control group were given salmeterol salmeterol fluticasone powder inhalation for treatment, the observation group given in the control group, given to patients with Renault test of budesonide nasal spray treatment, comparative analysis of two groups of patients receiving Therapeutic efficacy after a period of treatment. Results: The pulmonary function score, ACT score and allergic rhinitis score of the observation group were significantly better than those of the control group after treatment for some time. There was significant difference between the two groups (P < 0.05). Conclusion: The combination of diagnosis and treatment of allergic rhinitis and asthma patients not only helps to alleviate the various disease conditions of patients, enhance the therapeutic effect of patients, but also help to improve the quality of life of patients, which is worth to be popularized and applied clinically.